Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease

Cancer Biotherapy and Radiopharmaceuticals

Volumn 21, Issue 2, 2006, Pages 117-129

  Dadachova, Ekaterina ^a   Moadel, Tiffany ^a   Schweitzer, Andrew D ^a   Bryan, Ruth A ^a   Zhang, Tong ^a   Mints, Lisa ^a   Revskaya, Ekaterina ^a   Huang, Xianchuan ^a   Ortiz, Geraldina ^a   Nosanchuk, Jerome S ^b   Nosanchuk, Joshua D ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Animal Health Diagnostic Center   (United States)

Author keywords

188 Rhenium; Melanin; Melanin binding peptide; Melanoma; Nude mice; Radiolabeled peptides; Therapy

Indexed keywords

MELANIN; MELANIN BINDING DECAPEPTIDE RE 188; RHENIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; ISOTOPE LABELING; MELANOMA; MOUSE; NERVE CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BRAIN DISEASES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDRAZINES; IMMUNOTOXINS; KIDNEY DISEASES; MALE; MELANINS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NICOTINIC ACIDS; PEPTIDES; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33744827431     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2006.21.117     Document Type: Article

References (31)

1. Rigel DS. Malignant melanoma: Incidence issues and their effect on diagnosis and therapy in the 1990s. Mayo Clin Proc 1997;72:367.
2. Grin-Jorgensen CM, Rigel DS, Friedman RJ. The world-wide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong. SJ, eds. Cutaneous Melanoma, Ed. 2, Philadelphia: J.B. Lippincott Co., 1992:27.
3. Liu T, Soong SJ. Epidemiology of malignant melanoma. Surg Clin N Am 1996;76:1205.
4. Sun W, Schuchter LM. Metastatic melanoma. Curr Treat Options Oncol 2001;2:193.
5. Mandara M, Nortilli R, Sava T, et al. Chemotherapy for metastatic melanoma. Exp Rev Anticancer Ther 2006;6: 121.
6. Dadachova E, Nosanchuk JD, Shi L, et al. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a monoclonal antibody to melanin. Proc Natl Acad Sci USA 2004;101: 14865.
7. Krenning EP, Kwekkeboom DJ, Valkema R, et al. Peptide receptor radionuclide therapy. Ann NY Acad Sci 2004;1014:234.
8. Blok D, Feitsma RI, Vermeij P, et al. Peptide radiopharmaceuticals in nuclear medicine. Eur J Nucl Med 1999;26:1511.
9. Nosanchuk JD, Valadon P, Feldmesser M, et al. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 1999;19:745.
10. Rosas AL, Nosanchuk JD, Gomez BL, et al. Isolation and serological analyses of fungal melanins. J Immunol Meth 2000;244:69.
11. Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: Contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 1997;65:1836.
12. Blower PJ, Clark K, Link EM. Radioiodinated methylene blue for melanoma targeting: Chemical characterisation and tumour selectivity of labelled components. Nucl Med Biol 1997;24:305.
13. Abrams MJ, Juweid M, ten Kate CI, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazinonicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990;31:2022.
14. Westlin J-E, Janson ET, Ahlström H, et al. Scintigraphy using a 111-In-labeled somatostatin analogue for localization of neuroendocrine tumors. Antibody, Immunoconj Radiopharm 1992;5:367.
15. Kushimoto TA, Basrur V, Valencia J, et al. A model for melanosome biogenesis based on the purification and analysis of early melanosomes. Proc Natl Acad Sci USA 2001;98:10698.
16. Ito S, Fujita K. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal Biochem 1985;144:527.
17. Wakamatsu K, Ito S. Advanced chemical methods in melanin determination. Pigment Cell Res 2002;15:174.
18. Hui TE, Fisher DR, Kuhn JA, et al. A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates. Cancer 1994;73(Suppl):951.
19. Lambert B, Cybulla M, Weiner SM, et al. Renal toxicity after radionuclide therapy. Radiat Res 2004;161: 607.
20. Rogers DC, Fisher EM, Brown SD, et al. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997;8:711.
21. 188Re labeled somatostatin analogue RC160. [abstract] J Nucl Med 2001;42(Suppl):312.
22. Dadachova E, Casadevall A. Melanin as a potential target for radionuclide therapy of metastatic melanoma. Future Oncol 2005;1:541.
23. Miao Y, Whitener D, Feng W, et al. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues. Bioconjug Chem 2003;14:1177.
24. 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in mutine and human melanoma-bearing mouse models. J Nucl Med 2005;46:121.
25. Rice L, Wainwright M, Phoenix DA. Phenothiazine photosensitizers: III. Activity of methylene blue derivatives against pigmented melanoma cell lines. J Chemother 2000;12:94.
26. Hearing V. The melanosome: The perfect model for cellular responses to the environment. Pigment Cell Res 2000;13(Suppl 8):23.
27. 18F-FDG). Cancer Res 2005;65:698.
28. de long M, Breeman WA, Bernard BF, et al. Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med 2001; 42:1841.
29. Yukitake J, Otake H, Inoue S, et al. Comparison of in vivo antimelanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol. Melanoma Res 2004;14:115.
30. Chehade F, De Labriolle-Vaylet C, Michelot J, et al. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: A study by secondary ion mass spectroscopy (Noisy-legrand). Cell Mol Biol 2001;47:529.
31. Lindquist NG, Larsson BS, Lyden-Sokolowski A. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin. Neurosci Lett 1988;93:1.